World-first approach to improve melanoma outcomes arrives at The Alfred
Victorians at risk of melanoma now have access to cutting-edge 3D whole body imaging, which promises to improve detection and management of the deadly cancer.
COVID-19: Everything you need to know about patient and visitor information.
Victorians at risk of melanoma now have access to cutting-edge 3D whole body imaging, which promises to improve detection and management of the deadly cancer.
It was April last year, and Melbourne was in lockdown chaos. But Patricia McCabe had a much more personal crisis happening – she’d just found a lump under her arm, and it was breast cancer.
Matt was diagnosed with an aggressive brain tumour called a glioblastoma - he's recently completed six weeks of radiation therapy. For patients like Matt, after having brain surgery the next step in brain cancer treatment is radiation therapy and chemotherapy.
Treating brain cancer is a team effort, when a person is suspected of having a brain tumour they’ll begin their journey through treatment, starting with the first stop - Neuroradiology.
“When you have a brain tumour it never ends well. No one can predict how soon it might grow back. You’re dealt the hand your given, then you have to play it the best you can,” said Anthony.
Prostate, melanoma and rare cancer clinical trials will soon be available for patients in Gippsland thanks to a new partnership between Alfred Health and Latrobe Regional Hospital.
This year, the Victorian Melanoma Service (VMS) at The Alfred has seen a significant drop in referrals. But cases of melanoma have not dropped – prompting specialists to urge all Victorians to act now before it’s too late.
Between April and June this year, notifications of breast cancers decreased almost forty percent. Head of our breast surgery unit Dr Melanie Walker said, the COVID-19 restrictions should not be deterring people from seeing their GP for a breast examination if they have symptoms or concerns.
The Alfred has banded together with a private IVF company to save a patient's chance of having children after he was diagnosed with testicular cancer.
Alfred Cancer Trials (ACT) has begun testing two new Phase 1 cancer drugs, treating the first patients in the world on these trials.